{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T19:11:25Z","timestamp":1723662685099},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,22]]},"DOI":"10.7759\/cureus.62906","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T13:25:54Z","timestamp":1719062754000},"source":"Crossref","is-referenced-by-count":1,"title":["The First Reported Case of Treating the Ultra-Central Thorax With Cone Beam Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR)"],"prefix":"10.7759","author":[{"given":"Stephanie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbie","family":"Beckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Laugeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford G","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Vlacich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela P","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter A","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023, 20:624-39. 10.1038\/s41571-023-00798-3","journal-title":"Nat Rev Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman R","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, et al.. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010, 303:1070-6. 10.1001\/jama.2010.261","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang JY","year":"2015","unstructured":"Chang JY, Senan S, Paul MA, et al.. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015, 16:630-7. 10.1016\/S1470-2045(15)70168-3","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi H","year":"2007","unstructured":"Onishi H, Shirato H, Nagata Y, et al.. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007, 2:S94-100. 10.1097\/JTO.0b013e318074de34","journal-title":"J Thorac Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball D","year":"2019","unstructured":"Ball D, Mai GT, Vinod S, et al.. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. 2019, 20:494-503. 10.1016\/s1470-2045(18)30896-9","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg K","year":"2021","unstructured":"Lindberg K, Grozman V, Karlsson K, et al.. The HILUS-trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy. J Thorac Oncol. 2021, 16:1200-10. 10.1016\/j.jtho.2021.03.019","journal-title":"J Thorac Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak A","year":"2019","unstructured":"Bezjak A, Paulus R, Gaspar LE, et al.. Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial. J Clin Oncol. 2019, 37:1316-25. 10.1200\/JCO.18.00622","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \"ultracentral\" non-small cell lung cancer","volume":"11","author":"Tekatli H","year":"2016","unstructured":"Tekatli H, Haasbeek N, Dahele M, et al.. Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \"ultracentral\" non-small cell lung cancer. J Thorac Oncol. 2016, 11:1081-9. 10.1016\/j.jtho.2016.03.008","journal-title":"J Thorac Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2018.10.003","article-title":"Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: results of a phase 1 trial","volume":"4","author":"Henke LE","year":"2019","unstructured":"Henke LE, Olsen JR, Contreras JA, et al.. Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: results of a phase 1 trial. Adv Radiat Oncol. 2019, 4:201-9. 10.1016\/j.adro.2018.10.003","journal-title":"Adv Radiat Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110034","article-title":"Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART)","volume":"190","author":"Lee G","year":"2024","unstructured":"Lee G, Han Z, Huynh E, et al.. Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART). Radiother Oncol. 2024, 190:110034. 10.1016\/j.radonc.2023.110034","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2023.100488","article-title":"Magnetic resonance-guided stereotactic body radiation therapy\/hypofractionated radiation therapy for metastatic and primary central and ultracentral lung lesions","volume":"4","author":"Sandoval ML","year":"2023","unstructured":"Sandoval ML, Sim AJ, Bryant JM, et al.. Magnetic resonance-guided stereotactic body radiation therapy\/hypofractionated radiation therapy for metastatic and primary central and ultracentral lung lesions. JTO Clin Res Rep. 2023, 4:100488. 10.1016\/j.jtocrr.2023.100488","journal-title":"JTO Clin Res Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2023.101226","article-title":"Prospective in silico evaluation of cone-beam computed tomography-guided stereotactic adaptive radiation therapy (CT-STAR) for the ablative treatment of ultracentral thoracic disease","volume":"8","author":"Schiff JP","year":"2023","unstructured":"Schiff JP, Laugeman E, Stowe HB, et al.. Prospective in silico evaluation of cone-beam computed tomography-guided stereotactic adaptive radiation therapy (CT-STAR) for the ablative treatment of ultracentral thoracic disease. Adv Radiat Oncol. 2023, 8:101226. 10.1016\/j.adro.2023.101226","journal-title":"Adv Radiat Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2023.100692","article-title":"A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry","volume":"44","author":"Kiser K","year":"2024","unstructured":"Kiser K, Schiff J, Laugeman E, et al.. A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry. Clin Transl Radiat Oncol. 2024, 44:100692. 10.1016\/j.ctro.2023.100692","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.06.022","article-title":"In silico trial of MR-guided midtreatment adaptive planning for hypofractionated stereotactic radiation therapy in centrally located thoracic tumors","volume":"102","author":"Henke LE","year":"2018","unstructured":"Henke LE, Kashani R, Hilliard J, et al.. In silico trial of MR-guided midtreatment adaptive planning for hypofractionated stereotactic radiation therapy in centrally located thoracic tumors. Int J Radiat Oncol Biol Phys. 2018, 102:987-95. 10.1016\/j.ijrobp.2018.06.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman R","year":"2006","unstructured":"Timmerman R, McGarry R, Yiannoutsos C, et al.. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006, 24:4833-9. 10.1200\/JCO.2006.07.5937","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2015.09.012","article-title":"Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree","volume":"6","author":"Haseltine JM","year":"2016","unstructured":"Haseltine JM, Rimner A, Gelblum DY, et al.. Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree. Pract Radiat Oncol. 2016, 6:e27-33. 10.1016\/j.prro.2015.09.012","journal-title":"Pract Radiat Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.03.050","article-title":"Stereotactic radiation for ultra-central non-small cell lung cancer: a safety and efficacy trial (SUNSET)","volume":"24","author":"Giuliani ME","year":"2024","unstructured":"Giuliani ME, Filion E, Faria S, et al.. Stereotactic radiation for ultra-central non-small cell lung cancer: a safety and efficacy trial (SUNSET). Int J Radiat Oncol Biol Phys. 2024, 24:3016. 10.1016\/j.ijrobp.2024.03.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107281","article-title":"Stereotactic body radiotherapy for ultra-central lung tumors: a systematic review and meta-analysis and international stereotactic radiosurgery society practice guidelines","volume":"182","author":"Yan M","year":"2023","unstructured":"Yan M, Louie AV, Kotecha R, et al.. Stereotactic body radiotherapy for ultra-central lung tumors: a systematic review and meta-analysis and international stereotactic radiosurgery society practice guidelines. Lung Cancer. 2023, 182:107281. 10.1016\/j.lungcan.2023.107281","journal-title":"Lung Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-3-39","article-title":"CyberKnife for hilar lung tumors: report of clinical response and toxicity","volume":"3","author":"Unger K","year":"2010","unstructured":"Unger K, Ju A, Oermann E, et al.. CyberKnife for hilar lung tumors: report of clinical response and toxicity. J Hematol Oncol. 2010, 3:39. 10.1186\/1756-8722-3-39","journal-title":"J Hematol Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.04.014","article-title":"Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors","volume":"89","author":"Chaudhuri AA","year":"2015","unstructured":"Chaudhuri AA, Tang C, Binkley MS, et al.. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer. 2015, 89:50-6. 10.1016\/j.lungcan.2015.04.014","journal-title":"Lung Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0608-8","article-title":"Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases","volume":"11","author":"Lischalk JW","year":"2016","unstructured":"Lischalk JW, Malik RM, Collins SP, Collins BT, Matus IA, Anderson ED. Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases. Radiat Oncol. 2016, 11:28. 10.1186\/s13014-016-0608-8","journal-title":"Radiat Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.02.025","article-title":"Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors","volume":"107","author":"Finazzi T","year":"2020","unstructured":"Finazzi T, Haasbeek CJ, Spoelstra FO, et al.. Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors. Int J Radiat Oncol Biol Phys. 2020, 107:270-8. 10.1016\/j.ijrobp.2020.02.025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.05.366","article-title":"Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results","volume":"24","author":"Levy A","year":"2024","unstructured":"Levy A, Adebahr S, Hurkmans C, et al.. Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results. J Thorac Oncol. 2024, 24:577. 10.1016\/j.jtho.2024.05.366","journal-title":"J Thorac Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261074-the-first-reported-case-of-treating-the-ultra-central-thorax-with-cone-beam-computed-tomography-guided-stereotactic-adaptive-radiotherapy-ct-star","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T13:25:58Z","timestamp":1719062758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261074-the-first-reported-case-of-treating-the-ultra-central-thorax-with-cone-beam-computed-tomography-guided-stereotactic-adaptive-radiotherapy-ct-star"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,22]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.62906","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,22]]}}}